Phil Gutry - Net Worth and Insider Trading

Phil Gutry Net Worth

The estimated net worth of Phil Gutry is at least $953,812 dollars as of 2024-05-15. Phil Gutry is the CHIEF BUSINESS OFFICER of Graphite Bio Inc and owns about 299,941 shares of Graphite Bio Inc (GRPH) stock worth over $953,812. Details can be seen in Phil Gutry's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Phil Gutry has not made any transactions after 2022-04-11 and currently still holds the listed stock(s).

Transaction Summary of Phil Gutry

To

Phil Gutry Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Phil Gutry owns 2 companies in total, including Avalo Therapeutics Inc (AVTX) , and Graphite Bio Inc (GRPH) .

Click here to see the complete history of Phil Gutry’s form 4 insider trades.

Insider Ownership Summary of Phil Gutry

Ticker Comapny Transaction Date Type of Owner
AVTX Avalo Therapeutics Inc 2015-10-14 director
GRPH Graphite Bio Inc 2022-04-11 CHIEF BUSINESS OFFICER

Phil Gutry Latest Holdings Summary

Phil Gutry currently owns a total of 1 stock. Phil Gutry owns 299,941 shares of Graphite Bio Inc (GRPH) as of April 11, 2022, with a value of $953,812.

Latest Holdings of Phil Gutry

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GRPH Graphite Bio Inc 2022-04-11 299,941 3.18 953,812

Holding Weightings of Phil Gutry


Phil Gutry Form 4 Trading Tracker

According to the SEC Form 4 filings, Phil Gutry has made a total of 1 transactions in Graphite Bio Inc (GRPH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Graphite Bio Inc is the acquisition of 5,000 shares on April 11, 2022, which cost Phil Gutry around $20,050.

Insider Trading History of Phil Gutry

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Phil Gutry Trading Performance

GuruFocus tracks the stock performance after each of Phil Gutry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Phil Gutry is -22.06%. GuruFocus also compares Phil Gutry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Phil Gutry within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Phil Gutry's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Phil Gutry

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -43.63
Relative Return to S&P 500(%) -32.81

Phil Gutry Ownership Network

Ownership Network List of Phil Gutry

No Data

Ownership Network Relation of Phil Gutry


Phil Gutry Owned Company Details

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Phil Gutry is the director of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Phil Gutry made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 206,169 shares made by Caissa Capital Management Ltd. , a net sale of 3,233,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 6,083 shares made by Garry Arthur Neil .

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 2,762 shares were bought by its insiders, resulting in a net sale of 12,587 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Avalo Therapeutics Inc Insider Transactions

No Available Data

Phil Gutry Mailing Address

Above is the net worth, insider trading, and ownership report for Phil Gutry. You might contact Phil Gutry via mailing address: 400 E. Pratt Street, Suite 606, Baltimore Md 21202.

Discussions on Phil Gutry

No discussions yet.